FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
24,525,470
Share change
+1,061,224
Total reported value
$1,014,124,091
Put/Call ratio
1293%
Price per share
$41.35
Number of holders
169
Value change
+$45,574,694
Number of buys
115
Number of sells
59

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q2 2016

As of 30 Jun 2016, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 169 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,525,470 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, EVENTIDE ASSET MANAGEMENT, LLC, STATE STREET CORP, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., and RS INVESTMENT MANAGEMENT CO LLC. This page lists 169 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.